174417-54-0

Basic information

• Product Name: 2-BROMO-5-METHOXY-3-METHYLBENZOIC ACID
• Synonyms: 2-BROMO-5-METHOXY-3-METHYLBENZOIC ACID
• CAS NO: 174417-54-0
• Molecular Formula: C₉H₉BrO₃
• Molecular Weight: 245.08
• EINECS: 604-604-1
• Mol File: 174417-54-0.mol

Chemical Properties

• Boiling Point: 353.194°C at 760 mmHg
• Flash Point: 167.406°C
• Appearance: /
• Density: 1.547g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.575
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-BROMO-5-METHOXY-3-METHYLBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-5-METHOXY-3-METHYLBENZOIC ACID(174417-54-0)
• EPA Substance Registry System: 2-BROMO-5-METHOXY-3-METHYLBENZOIC ACID(174417-54-0)

Safety Data

• Hazardous Substances Data: 174417-54-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-5-methoxy-3-methylbenzoic acid is used as an intermediate in organic synthesis for the production of various drugs and other organic compounds. Its unique structure and properties make it a promising candidate in the development of new pharmaceuticals with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-Bromo-5-methoxy-3-methylbenzoic acid is utilized as a key intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its reactivity and biological activity contribute to the effectiveness of these compounds in controlling pests and promoting crop growth.

InChI:InChI=1/C9H9BrO3/c1-5-3-6(13-2)4-7(8(5)10)9(11)12/h3-4H,1-2H3,(H,11,12)

Upstream product

• 6267-34-1 2-bromo-5-methoxy-1,3-dimethyl-benzene 
• 110451-90-6 (2-bromo-5-methoxy-3-methylphenyl)methanol 
• 874-63-5 3,5-dimethylmethoxybenzene 
• 164513-49-9 2-bromo-1-(bromomethyl)-5-methoxy-3-methylbenzene 
• 108-68-9 3,5-Dimethylphenol 
• 1336-21-6 ammonium hydroxide 

Downstream Products

• 94742-92-4 methyl 2-bromo-5-methoxy-3-methylbenzoate 
• 207287-39-6 (S)-2-(2-Bromo-5-methoxy-3-methyl-phenyl)-4-isopropyl-4,5-dihydro-oxazole 
• 174417-56-2 1-Allyl-1-(2-bromo-5-methoxy-3-methyl-phenyl)-5,7-dimethoxy-1,3-dihydro-isobenzofuran 
• 174417-55-1 Acetic acid 2-(2-bromo-5-methoxy-3-methyl-benzoyl)-3,5-dimethoxy-benzyl ester 
• 174417-57-3 3-[1-(2-Bromo-5-methoxy-3-methyl-phenyl)-5,7-dimethoxy-3-oxo-1,3-dihydro-isobenzofuran-1-yl]-propionic acid 
• 631910-81-1 (2-bromo-5-methoxy-3-methyl-phenyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions

Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula I or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R1, R2, R3, R4 and R7 are defined in the specification, Z is SO or SO2, and Ar is an aromatic or heteroaromatic group as defined herein.

New 2,2′-substituted 4,4′-dimethoxy-6,6′-dimethyl[1, 1′-biphenyls], inducing a strong helical twisting power in liquid crystals

Based on the stabilisation of the molecular motion by the chiral residue, novel optically active biphenylic chiral dopants for nematic liquid crystals were developed. This molecular congestion was obtained by introducing mesogenic residues on the 2,2′-positions of the chiral biphenyl; this led to a novel molecular architecture that was found to be efficient. The synthesised optically active biphenyls were characterised with very short cholesteric pitches when used as chiral dopants in nematic liquid crystals. The synthesis of the enatiomerically pure biphenyl dopants and their preliminary physicochemical characterisations are described.

NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS

Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula (I) or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R1, R2, R3, R4 and R7 are defined in the specification, Z is SO or SO2, and Ar is an aromatic or heteroaromatic group as defined herein.

A New Family of Enantiomerically Pure Smectic C* Liquid Crystals with a Bridged Chiral Biphenyl Core

The synthesis of enantiomerically pure bridged biphenyl compounds, (-)-(R)-3,9-bis(4-(dodecyloxy)benzoyloxy)-5,7-dihydro-1,11-dimethyldibenzo[c,e] thiepine, 13, and (-)-(R)-3,9-bis(4-(dodecyloxy)benzoyloxy)-5,7-dihydro-1,11-dimethyldibenzo[c,e]- thiepin d

SYNTHESIS OF OPTICALLY ACTIVE O,O,O-TRIMETHYLKORUPENSAMINES A AND B

Hydrolysis of benzofuran derivative (10) with concomitant aromatisation produced the biaryl system (11).Subsequent Sharpless asymmetric epoxidation of the cinnamyl alcohol (13) gave atropisomers (14) and (15) conveniently separated by chromatography.Indep